Author Topic: (Abst.) Severe disease activity in a patient w/MS after daclizumab discontinuation  (Read 37 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 8124
  • MS diagnosed 1980
  • Location: Pacific Northwest

From PubMed, December 17, 2018--"Severe disease activity in a patient with multiple sclerosis after daclizumab discontinuation":


https://www.ncbi.nlm.nih.gov/pubmed/30554038

Daclizumab (Zinbryta) has been taken off the market. For some background, here is a thread from a few months ago about it:


https://msspeaks.createaforum.com/treatments/zinbryta-being-pulled-from-market-due-to-safety-concerns/msg2172/#msg2172

MS Speaks--online for 12 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
70 Views
Last post April 07, 2016, 02:12:24 pm
by agate
1 Replies
99 Views
Last post January 19, 2017, 04:23:36 pm
by agate
0 Replies
50 Views
Last post August 22, 2017, 05:52:26 am
by agate
2 Replies
71 Views
Last post December 26, 2018, 11:46:15 am
by agate
0 Replies
30 Views
Last post August 03, 2018, 09:29:58 pm
by agate